Liotta LA - Search Results

1

Phosphoproteomic analysis of signaling pathways in head and neck squamous cell carcinoma patient samples.

Frederick MJ, VanMeter AJ, Gadhikar MA, Henderson YC, Yao H, Pickering CC, Williams MD, El-Naggar AK, Sandulache V, Tarco E, Myers JN, Clayman GL, Liotta LA, Petricoin EF 3rd, Calvert VS, Fodale V, Wang J, Weber RS. Frederick MJ, et al. Among authors: liotta la. Am J Pathol. 2011 Feb;178(2):548-71. doi: 10.1016/j.ajpath.2010.10.044. Am J Pathol. 2011. PMID: 21281788 Free PMC article.

2

Reverse phase protein microarrays for theranostics and patient-tailored therapy.

Espina V, Wulfkuhle J, Calvert VS, Liotta LA, Petricoin EF 3rd. Espina V, et al. Among authors: liotta la. Methods Mol Biol. 2008;441:113-28. doi: 10.1007/978-1-60327-047-2_8. Methods Mol Biol. 2008. PMID: 18370315

3

Array-based proteomics: mapping of protein circuitries for diagnostics, prognostics, and therapy guidance in cancer.

Gulmann C, Sheehan KM, Kay EW, Liotta LA, Petricoin EF 3rd. Gulmann C, et al. Among authors: liotta la. J Pathol. 2006 Apr;208(5):595-606. doi: 10.1002/path.1958. J Pathol. 2006. PMID: 16518808 Review.

4

Proteomic approaches in cancer risk and response assessment.

Petricoin EF, Liotta LA. Petricoin EF, et al. Among authors: liotta la. Trends Mol Med. 2004 Feb;10(2):59-64. doi: 10.1016/j.molmed.2003.12.006. Trends Mol Med. 2004. PMID: 15102358 Review.

5

Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.

Calvo KR, Liotta LA, Petricoin EF. Calvo KR, et al. Among authors: liotta la. Biosci Rep. 2005 Feb-Apr;25(1-2):107-25. doi: 10.1007/s10540-005-2851-3. Biosci Rep. 2005. PMID: 16222423 Review.

6

The promise of proteomics.

Liotta LA, Petricoin EF 3rd. Liotta LA, et al. Clin Adv Hematol Oncol. 2003 Aug;1(8):460-2. Clin Adv Hematol Oncol. 2003. PMID: 16258432 Review. No abstract available.

7

Reverse phase protein microarrays for monitoring biological responses.

Espina V, Wulfkuhle JD, Calvert VS, Petricoin EF 3rd, Liotta LA. Espina V, et al. Among authors: liotta la. Methods Mol Biol. 2007;383:321-36. doi: 10.1007/978-1-59745-335-6_21. Methods Mol Biol. 2007. PMID: 18217695

8

Reverse-phase protein microarrays for theranostics and patient tailored therapy.

Espina V, Liotta LA, Petricoin EF 3rd. Espina V, et al. Among authors: liotta la. Methods Mol Biol. 2009;520:89-105. doi: 10.1007/978-1-60327-811-9_7. Methods Mol Biol. 2009. PMID: 19381949

9

Quantitative cell signalling analysis reveals down-regulation of MAPK pathway activation in colorectal cancer.

Gulmann C, Sheehan KM, Conroy RM, Wulfkuhle JD, Espina V, Mullarkey MJ, Kay EW, Liotta LA, Petricoin EF 3rd. Gulmann C, et al. Among authors: liotta la. J Pathol. 2009 Aug;218(4):514-9. doi: 10.1002/path.2561. J Pathol. 2009. PMID: 19396842

10

Protein pathway biomarker analysis of human cancer reveals requirement for upfront cellular-enrichment processing.

Silvestri A, Colombatti A, Calvert VS, Deng J, Mammano E, Belluco C, De Marchi F, Nitti D, Liotta LA, Petricoin EF, Pierobon M. Silvestri A, et al. Among authors: liotta la. Lab Invest. 2010 May;90(5):787-96. doi: 10.1038/labinvest.2010.47. Epub 2010 Mar 1. Lab Invest. 2010. PMID: 20195244 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

691 results

Search Page

Filters